Reactivation of latent herpes simplex many result in visually disabling keratitis and is the most common cause of corneal blindness due to an infectious agent in the United States. We have developed a murine model of recurrent herpetic keratitis using a naturally occurring stimulus -- ultraviolet B light -- that consistently results in recoverable virus at the ocular surface in at least 70% of irradiated latently-infected animals. It is now proposed to further characterized and exploit the model with regard to the following Specific Aims which are critical to our understanding of the basic biology of herpetic reactivation in vivo: (1) to characterize viral immediate-early gene expression in trigeminal ganglia neurons in the period following UV-B induced reactivation in vivo; (2) identification of HSV-1 genes and promoters essential for viral reactivation in vivo by creation of intratypic recombinants and selection in the UV-B reactivation model; (3) to utilize antibodies to neuropeptides and cell surface carbohydrates to characterize the neuronal cell types in the trigeminal ganglia in which latency is established an in which viral reactivation occurs following the UV-B stimulus. This information will greatly enhance our understanding of viral reactivation and may be useful in the future in the directed design of antiviral drugs, as well as prophylactic agents to prevent viral reactivation itself.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
1R01EY009751-01A2
Application #
2163481
Study Section
Visual Sciences A Study Section (VISA)
Project Start
1993-12-01
Project End
1996-11-30
Budget Start
1993-12-01
Budget End
1994-11-30
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Washington University
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Stuart, P M; Griffith, T S; Usui, N et al. (1997) CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 99:396-402
Valluri, S; Fleming, T P; Laycock, K A et al. (1997) In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection. Cornea 16:556-9
Keadle, T L; Laycock, K A; Miller, J K et al. (1997) Efficacy of a recombinant glycoprotein D subunit vaccine on the development of primary and recurrent ocular infection with herpes simplex virus type 1 in mice. J Infect Dis 176:331-8
Stuart, P M; Usui, N; Randhawa, R S et al. (1997) Differential effects of HSV-1 and HCMV infection on adhesion molecule expression on human corneal keratocytes. Curr Eye Res 16:496-502
Miller, J K; Laycock, K A; Umphress, J A et al. (1996) A comparison of recurrent and primary herpes simplex keratitis in NIH inbred mice. Cornea 15:497-504
Strelow, L I; Laycock, K A; Jun, P Y et al. (1994) A structural and functional comparison of the latency-associated transcript promoters of herpes simplex virus type 1 strains KOS and McKrae. J Gen Virol 75 ( Pt 9):2475-80